MicroRNA-30a-5p in the prefrontal cortex controls the transition from moderate to excessive alcohol consumption

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) regulate gene expression by degrading messenger RNA (mRNA) or inhibiting translation.
• Brain-derived neurotrophic factor (BDNF) signaling in the prefrontal cortex (PFC) is crucial for moderating alcohol intake.
• Dysregulation of the BDNF pathway is implicated in the transition from moderate to excessive alcohol consumption.

Purpose of the Study:

• To investigate the role of miRNAs in the breakdown of the endogenous protective pathway against excessive alcohol intake.
• To identify specific miRNAs involved in regulating BDNF expression in the medial PFC (mPFC) in response to alcohol exposure.
• To determine if targeting specific miRNAs can modulate alcohol consumption behaviors.

Main Methods:

• Utilized a mouse model mimicking human binge alcohol drinking patterns.
• Measured BDNF mRNA levels and miRNA expression in the mPFC.
• Assessed the direct interaction between miR-30a-5p and BDNF mRNA using 3' untranslated region (UTR) binding assays.
• Manipulated miR-30a-5p levels in the mPFC via overexpression and inhibition (using Locked Nucleic Acid sequences).
• Quantified changes in alcohol intake and preference in response to miRNA manipulation.

Main Results:

• Binge alcohol drinking significantly reduced BDNF mRNA levels in the mPFC.
• Expression of miR-30a-5p was significantly increased following binge alcohol exposure.
• Overexpression of miR-30a-5p in the mPFC decreased BDNF expression and escalated alcohol intake.
• Inhibition of miR-30a-5p restored BDNF levels and reduced excessive alcohol consumption.
• miR-30a-5p was confirmed to bind to the 3' UTR of BDNF mRNA.

Conclusions:

• miR-30a-5p plays a critical role in the transition from moderate to uncontrolled alcohol intake.
• The breakdown of the BDNF protective pathway involves a miRNA-dependent mechanism mediated by miR-30a-5p.
• Targeting miR-30a-5p in the mPFC presents a potential therapeutic strategy for managing alcohol use disorder.